The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The Role of the TGF-β Superfamily in Myocardial Infarction
Open accessAbstract
The members of the transforming growth factor β (TGF-β) superfamily are essential regulators of cell differentiation, phenotype and function, and have been implicated in the pathogenesis of many diseases. Myocardial infarction is associated with induction of several members of the superfamily, including TGF-β1, TGF-β2, TGF-β3, bone morphogenetic protein (BMP)-2, BMP-4, BMP-10, growth differentiation factor (GDF)-8, GDF-11 and activin A. This manuscript reviews our current knowledge on the patterns and mechanisms of regulation and activation of TGF-β superfamily members in the infarcted heart, and discusses their cellular actions and downstream signaling mechanisms. In the infarcted heart, TGF-β isoforms modulate cardiomyocyte survival and hypertrophic responses, critically regulate immune cell function, activate fibroblasts, and stimulate a matrix-preserving program. BMP subfamily members have been suggested to exert both pro- and anti-inflammatory actions and may regulate fibrosis. Members of the GDF subfamily may also modulate survival and hypertrophy of cardiomyocytes and regulate inflammation. Important actions of TGF-β superfamily members may be mediated through activation of Smad-dependent or non-Smad pathways. The critical role of TGF-β signaling cascades in cardiac repair, remodeling, fibrosis, and regeneration may suggest attractive therapeutic targets for myocardial infarction patients. However, the pleiotropic, cell-specific, and context-dependent actions of TGF-β superfamily members pose major challenges in therapeutic translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 1×
“Effects of TGF-β on Endothelial Cell Phenotype and on Infarct Angiogenesis Endothelial cells, the most abundant non-cardiomyocytes in the adult mammalian myocardium (83), play an important role in regulation of the post-infarction inflammatory response and in repair of the infarcted heart.”
BackgroundLoffredo, F. S., Steinhauser, M. L., Jay, S. M., Gannon, J., Pancoast, J. R., Yalamanchi, P., Sinha, M., Dall’Osso, C., Khong, D., Shadrach, J. L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.015 · Cited by 948 · cited 1×
“GDF11 Publication of a high impact study suggesting that GDF11 levels decline with aging and that GDF11 administration may reverse age-related hypertrophy (148) (Figure 1) generated great interest in the potential role of this approach as therapy to reverse aging in many tissues (149).”
BackgroundCucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786
Signaling Receptors for TGF-β Family Members
Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711
Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202805.73038.48 · Cited by 651
Zhang, F., Wang, H., Wang, X., Jiang, G., Liu, H., Zhang, G., Wang, H., Fang, R., Bu, X., Cai, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10561 · Cited by 580
van Amerongen, M. J., Harmsen, M. C., van Rooijen, N., Petersen, A. H., & van Luyn, M. J. A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060547 · Cited by 544
Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning
Ma, L., Lu, M.-F., Schwartz, R. J., & Martin, J. F. (2005) · Development · doi:10.1242/dev.02156 · Cited by 525
Research works printed but not linked: 178
- Frangogiannis, 2015, Pathophysiology of myocardial infarction, Compr Physiol., 5, 1841, 10.1002/cphy.c150006 · DOI · Paper page
- Reimer, 1977, The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs, Circulation., 56, 786, 10.1161/01.CIR.56.5.786 · DOI · Paper page
- Frangogiannis, 2012, Regulation of the inflammatory response in cardiac repair, Circ Res., 110, 159, 10.1161/CIRCRESAHA.111.243162 · DOI · Paper page
- Frangogiannis, 2017, The role of transforming growth factor (TGF)-beta in the infarcted myocardium, J Thorac Dis., 9, S52, 10.21037/jtd.2016.11.19 · DOI
- Thompson, 1989, Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice, J Cell Biol., 108, 661, 10.1083/jcb.108.2.661 · DOI · Paper page
- Heine, 1987, Role of transforming growth factor-beta in the development of the mouse embryo, J Cell Biol., 105, 2861, 10.1083/jcb.105.6.2861 · DOI · Paper page
- Bartram, 2001, Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-β(2)-knockout mice, Circulation., 103, 2745, 10.1161/01.CIR.103.22.2745 · DOI · Paper page
- Umbarkar, 2019, Cardiomyocyte SMAD4-dependent TGF-β signaling is essential to maintain adult heart homeostasis, JACC Basic Transl Sci., 4, 41, 10.1016/j.jacbts.2018.10.003 · DOI
- Roberts, 1992, Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1, J Clin Invest., 90, 2056, 10.1172/JCI116087 · DOI
- Dewald, 2004, Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction, Am J Pathol., 164, 665, 10.1016/S0002-9440(10)63154-9 · DOI · Paper page
- Wunsch, 1991, In situ localization of transforming growth factor beta 1 in porcine heart: enhanced expression after chronic coronary artery constriction, J Mol Cell Cardiol., 23, 1051, 10.1016/0022-2828(91)91640-D · DOI
- Vilahur, 2011, Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction, J Mol Cell Cardiol., 50, 522, 10.1016/j.yjmcc.2010.12.021 · DOI · Paper page
- Hao, 1999, Elevation of expression of Smads 2, 3, and 4, decorin and TGF-β in the chronic phase of myocardial infarct scar healing, J Mol Cell Cardiol., 31, 667, 10.1006/jmcc.1998.0902 · DOI · Paper page
- Deten, 2001, Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats, J Mol Cell Cardiol., 33, 1191, 10.1006/jmcc.2001.1383 · DOI · Paper page
- Bujak, 2007, The role of TGF-β signaling in myocardial infarction and cardiac remodeling, Cardiovasc Res., 74, 184, 10.1016/j.cardiores.2006.10.002 · DOI · Paper page
- Dewald, 2005, CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ Res., 96, 881, 10.1161/01.RES.0000163017.13772.3a · DOI · Paper page
- Jia, 2019, Interleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice, Circ Res., 124, 1323, 10.1161/CIRCRESAHA.118.314569 · DOI
- Meyer, 2012, Platelet TGF-β 1 contributions to plasma TGF-β 1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload, Blood., 119, 1064, 10.1182/blood-2011-09-377648 · DOI · Paper page
- Saxena, 2014, Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function, Am J Physiol Heart Circ Physiol., 307, H1233, 10.1152/ajpheart.00328.2014 · DOI · Paper page
- Weirather, 2014, Foxp3+CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation, Circ Res., 115, 55, 10.1161/CIRCRESAHA.115.303895 · DOI · Paper page
- Frangogiannis, 1998, Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion, Circulation., 98, 687, 10.1161/01.CIR.98.7.687 · DOI · Paper page
- Annes, 2003, Making sense of latent TGFbeta activation, J Cell Sci., 116, 217, 10.1242/jcs.00229 · DOI · Paper page
- Gentry, 1990, The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor, Biochemistry., 29, 6851, 10.1021/bi00481a014 · DOI · Paper page
- Birdsall, 1997, Complement C5a, TGF-β 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion, Circulation., 95, 684, 10.1161/01.CIR.95.3.684 · DOI · Paper page
- Bujak, 2007, Essential role of smad3 in infarct healing and in the pathogenesis of cardiac remodeling, Circulation., 116, 2127, 10.1161/CIRCULATIONAHA.107.704197 · DOI · Paper page
- Nishimura, 2009, Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders, Am J Pathol., 175, 1362, 10.2353/ajpath.2009.090393 · DOI
- Sarrazy, 2014, Integrins αvβ5 and αvβ3 promote latent TGF-β 1 activation by human cardiac fibroblast contraction, Cardiovasc Res., 102, 407, 10.1093/cvr/cvu053 · DOI · Paper page
- Spinale, 2007, Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function, Physiol Rev., 87, 1285, 10.1152/physrev.00012.2007 · DOI · Paper page
- Villarreal, 2004, Early degradation and serum appearance of type I collagen fragments after myocardial infarction, J Mol Cell Cardiol., 36, 597, 10.1016/j.yjmcc.2004.01.004 · doi:10.1016/j.yjmcc.2004.01.004
- Liu, 2018, Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials, Nat Rev Cardiol., 15, 351, 10.1038/s41569-018-0002-3 · DOI · Paper page
- Frangogiannis, 2005, The critical role of endogenous Thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts, Circulation., 111, 2935, 10.1161/CIRCULATIONAHA.104.510354 · DOI · Paper page
- Frangogiannis, 2012, Matricellular proteins in cardiac adaptation and disease, Physiol Rev., 92, 635, 10.1152/physrev.00008.2011 · DOI · Paper page
- Schellings, 2004, Matricellular proteins in the heart: possible role during stress and remodeling, Cardiovasc Res., 64, 24, 10.1016/j.cardiores.2004.06.006 · DOI · Paper page
- Murphy-Ullrich, 2000, Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology, Cytokine Growth Factor Rev., 11, 59, 10.1016/S1359-6101(99)00029-5 · DOI · Paper page
- Lefer, 1990, Mediation of cardioprotection by transforming growth factor-beta, Science., 249, 61, 10.1126/science.2164258 · DOI · Paper page
- Lefer, 1993, Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion, Proc Natl Acad Sci USA., 90, 1018, 10.1073/pnas.90.3.1018 · DOI
- Baxter, 2001, Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK, J Cardiovasc Pharmacol., 38, 930, 10.1097/00005344-200112000-00015 · DOI
- Schroder, 2006, Angiotensin II stimulates apoptosis via TGF-β 1 signaling in ventricular cardiomyocytes of rat, J Mol Med., 84, 975, 10.1007/s00109-006-0090-0 · DOI
- Wenzel, 2010, TGF-β 1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes, Basic Res Cardiol., 105, 621, 10.1007/s00395-010-0108-1 · doi:10.1007/s00395-010-0108-1
- Rainer, 2014, Cardiomyocyte-specific transforming growth factor beta suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction, Circ Res., 114, 1246, 10.1161/CIRCRESAHA.114.302653 · DOI
- Travis, 2014, TGF-β activation and function in immunity, Annu Rev Immunol., 32, 51, 10.1146/annurev-immunol-032713-120257 · DOI · Paper page
- Fava, 1991, Transforming growth factor beta 1 (TGF-β 1) induced neutrophil recruitment to synovial tissues: implications for TGF-β -driven synovial inflammation and hyperplasia, J Exp Med., 173, 1121, 10.1084/jem.173.5.1121 · DOI · Paper page
- Wahl, 1987, Transforming growth factor type beta induces monocyte chemotaxis and growth factor production, Proc Natl Acad Sci USA., 84, 5788, 10.1073/pnas.84.16.5788 · DOI · Paper page
- Smith, 1996, Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium, J Immunol., 157, 360, 10.4049/jimmunol.157.1.360 · DOI · Paper page
- Letterio, 1998, Regulation of immune responses by TGF-β, Annu Rev Immunol., 16, 137, 10.1146/annurev.immunol.16.1.137 · DOI · Paper page
- Werner, 2000, Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3, J Biol Chem., 275, 36653, 10.1074/jbc.M004536200 · DOI · Paper page
- Feinberg, 2004, Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation, Circ Res., 94, 601, 10.1161/01.RES.0000119170.70818.4F · DOI
- Kitamura, 1996, Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells, J Immunol., 156, 2964, 10.4049/jimmunol.156.8.2964 · doi:10.4049/jimmunol.156.8.2964
- Gorelik, 2000, Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease, Immunity., 12, 171, 10.1016/S1074-7613(00)80170-3 · DOI · Paper page
- Dutta, 2015, Monocytes in myocardial infarction, Arterioscler Thromb Vasc Biol., 35, 1066, 10.1161/ATVBAHA.114.304652 · DOI · Paper page
- Shiraishi, 2016, Alternatively activated macrophages determine repair of the infarcted adult murine heart, J Clin Invest., 126, 2151, 10.1172/JCI85782 · DOI · Paper page
- Ikeuchi, 2004, Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction, Cardiovasc Res., 64, 526, 10.1016/j.cardiores.2004.07.017 · DOI · Paper page
- Xiao, 2006, Oxidants selectively reverse TGF-β suppression of proinflammatory mediator production, J Immunol., 176, 1209, 10.4049/jimmunol.176.2.1209 · DOI
- Celada, 1992, Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages, J Immunol., 148, 1102, 10.4049/jimmunol.148.4.1102 · DOI
- Ding, 1990, Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma, J Immunol., 145, 940, 10.4049/jimmunol.145.3.940 · DOI · Paper page
- Nelson, 1991, Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1, J Immunol., 146, 1849, 10.4049/jimmunol.146.6.1849 · DOI
- Oh, 2013, TGF-β: guardian of T cell function, J Immunol., 191, 3973, 10.4049/jimmunol.1301843 · DOI · Paper page
- Chen, 2015, Development of thymic Foxp3(+) regulatory T cells: TGF-β matters, Eur J Immunol., 45, 958, 10.1002/eji.201444999 · DOI
- Wahl, 2004, TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells, J Leukoc Biol., 76, 15, 10.1189/jlb.1103539 · DOI · Paper page
- Hofmann, 2012, Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice, Circulation., 125, 1652, 10.1161/CIRCULATIONAHA.111.044164 · DOI · Paper page
- Kanisicak, 2016, Genetic lineage tracing defines myofibroblast origin and function in the injured heart, Nat Commun., 7, 12260, 10.1038/ncomms12260 · DOI · Paper page
- Ruiz-Villalba, 2015, Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar, J Am Coll Cardiol., 65, 2057, 10.1016/j.jacc.2015.03.520 · DOI
- Frangogiannis, 2000, Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb), Cardiovasc Res., 48, 89, 10.1016/S0008-6363(00)00158-9 · DOI · Paper page
- Shinde, 2014, Fibroblasts in myocardial infarction: a role in inflammation and repair, J Mol Cell Cardiol., 74, 10.1016/j.yjmcc.2013.11.015 · DOI · Paper page
- Cleutjens, 1995, Collagen remodeling after myocardial infarction in the rat heart, Am J Pathol., 147, 325
- Shinde, 2017, Mechanisms of fibroblast activation in the remodeling myocardium, Curr Pathobiol Rep., 5, 145, 10.1007/s40139-017-0132-z · DOI
- Humeres, 2019, Fibroblasts in the infarcted, remodeling, and failing heart, JACC Basic Transl Sci., 4, 449, 10.1016/j.jacbts.2019.02.006 · DOI · Paper page
- Shinde, 2017, The role of alpha-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling, Biochim Biophys Acta., 1863, 298, 10.1016/j.bbadis.2016.11.006 · DOI · Paper page
- Eghbali, 1991, Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors, Circ Res., 69, 483, 10.1161/01.RES.69.2.483 · DOI · Paper page
- Chua, 1991, Effect of growth factors on collagen metabolism in cultured human heart fibroblasts, Connect Tissue Res., 26, 271, 10.3109/03008209109152444 · DOI
- Russo, 2019, Protective effects of activated myofibroblasts in the pressure-overloaded myocardium are mediated through smad-dependent activation of a matrix-preserving program, Circ Res., 124, 1214, 10.1161/CIRCRESAHA.118.314438 · DOI
- Yi, 2014, Hepatocyte growth factor regulates the TGF-β 1-induced proliferation, differentiation and secretory function of cardiac fibroblasts, Int J Mol Med., 34, 381, 10.3892/ijmm.2014.1782 · DOI
- Frantz, 2008, Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction, Basic Res Cardiol., 103, 485, 10.1007/s00395-008-0739-7 · DOI · Paper page
- Okada, 2005, Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure, Circulation., 111, 2430, 10.1161/01.CIR.0000165066.71481.8E · DOI · Paper page
- Frangogiannis, 2007, Chemokines in ischemia and reperfusion, Thromb Haemost., 97, 738, 10.1160/TH07-01-0022 · DOI · Paper page
- Kumar, 1997, Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium, Circulation., 95, 693, 10.1161/01.CIR.95.3.693 · doi:10.1161/01.cir.95.3.693
- Frangogiannis, 2014, The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities, J Cardiovasc Pharmacol., 63, 185, 10.1097/FJC.0000000000000003 · DOI · Paper page
- Virag, 2003, Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair, Am J Pathol., 163, 2433, 10.1016/S0002-9440(10)63598-5 · DOI · Paper page
- Ren, 2002, Morphological characteristics of the microvasculature in healing myocardial infarcts, J Histochem Cytochem., 50, 71, 10.1177/002215540205000108 · DOI · Paper page
- Dobaczewski, 2004, Vascular mural cells in healing canine myocardial infarcts, J Histochem Cytochem., 52, 1019, 10.1369/jhc.3A6210.2004 · DOI
- Zymek, 2006, The role of platelet-derived growth factor signaling in healing myocardial infarcts, J Am Coll Cardiol., 48, 2315, 10.1016/j.jacc.2006.07.060 · DOI · Paper page
- Pepper, 1997, Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity, Cytokine Growth Factor Rev., 8, 21, 10.1016/S1359-6101(96)00048-2 · DOI · Paper page
- Frangogiannis, 2001, Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis, FASEB J., 15, 1428, 10.1096/fj.00-0745fje · DOI
- Pardali, 2009, Transforming growth factor-beta signaling and tumor angiogenesis, Front Biosci., 14, 4848, 10.2741/3573 · DOI
- Massague, 2012, TGF-β control of stem cell differentiation genes, FEBS Lett., 586, 1953, 10.1016/j.febslet.2012.03.023 · DOI · Paper page
- Chablais, 2012, The regenerative capacity of the zebrafish heart is dependent on TGFβ signaling, Development., 139, 1921, 10.1242/dev.078543 · DOI · Paper page
- Chen, 2015, Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration, Cardiovasc Res., 105, 44, 10.1093/cvr/cvu229 · DOI
- Behfar, 2002, Stem cell differentiation requires a paracrine pathway in the heart, Faseb J., 16, 1558, 10.1096/fj.02-0072com · DOI · Paper page
- Willems, 2012, Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells, Cell Stem Cell., 11, 242, 10.1016/j.stem.2012.04.025 · DOI
- Chen, 2012, Small molecule regulators of postnatal Nkx2.5 cardiomyoblast proliferation and differentiation, J Cell Mol Med., 16, 961, 10.1111/j.1582-4934.2011.01513.x · doi:10.1111/j.1582-4934.2011.01513.x
- Li, 2005, Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells, Circulation., 111, 2438, 10.1161/01.CIR.0000167553.49133.81 · DOI
- Wu, 2019, Bone morphogenetic protein signaling in inflammation, Exp Biol Med., 244, 147, 10.1177/1535370219828694 · DOI
- Mueller, 2012, Promiscuity and specificity in BMP receptor activation, FEBS Lett., 586, 1846, 10.1016/j.febslet.2012.02.043 · DOI · Paper page
- Morrell, 2016, Targeting BMP signalling in cardiovascular disease and anaemia, Nat Rev Cardiol., 13, 106, 10.1038/nrcardio.2015.156 · DOI · Paper page
- Noseda, 2011, Cardiopoietic factors: extracellular signals for cardiac lineage commitment, Circ Res., 108, 129, 10.1161/CIRCRESAHA.110.223792 · DOI
- Monzen, 1999, Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4, Mol Cell Biol., 19, 7096, 10.1128/MCB.19.10.7096 · DOI · Paper page
- Zhang, 1996, Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development, Development., 122, 2977, 10.1242/dev.122.10.2977 · DOI · Paper page
- Ghosh-Choudhury, 2003, BMP-2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase-dependent manner, FEBS Lett., 544, 181, 10.1016/S0014-5793(03)00507-6 · DOI
- Sanders, 2016, BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction, Circ Res., 119, 434, 10.1161/CIRCRESAHA.116.308700 · DOI
- Rutkovskiy, 2017, Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans, Scand J Clin Lab Invest., 77, 321, 10.1080/00365513.2017.1318447 · DOI
- Chang, 2008, Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation, Stem Cells., 26, 1901, 10.1634/stemcells.2007-0708 · DOI
- Izumi, 2001, Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway, J Biol Chem., 276, 31133, 10.1074/jbc.M101463200 · DOI
- Ebelt, 2013, Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice, Shock., 39, 353, 10.1097/SHK.0b013e318289728a · DOI
- Yang, 2009, Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors, Endocrinology., 150, 727, 10.1210/en.2008-0090 · DOI
- Benn, 2017, Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence, FASEB J., 31, 4720, 10.1096/fj.201700193RR · DOI
- Cagavi, 2014, Functional cardiomyocytes derived from Isl1 cardiac progenitors via Bmp4 stimulation, PLoS ONE., 9, e110752, 10.1371/journal.pone.0110752 · DOI
- Takei, 2009, Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development, Am J Physiol Heart Circ Physiol., 296, H1793, 10.1152/ajpheart.01288.2008 · DOI
- Wu, 2014, Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart, Life Sci., 97, 145, 10.1016/j.lfs.2013.12.030 · DOI
- Lu, 2014, Bone morphogenetic protein-2 antagonizes bone morphogenetic protein-4 induced cardiomyocyte hypertrophy and apoptosis, J Cell Physiol., 229, 1503, 10.1002/jcp.24592 · DOI
- Pachori, 2010, Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway, J Mol Cell Cardiol., 48, 1255, 10.1016/j.yjmcc.2010.01.010 · DOI
- Sun, 2013, Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy, Hypertension., 61, 352, 10.1161/HYPERTENSIONAHA.111.00562 · DOI
- Li, 2014, Bone morphogenetic protein 4 inhibits liposaccharide-induced inflammation in the airway, Eur J Immunol., 44, 3283, 10.1002/eji.201344287 · DOI
- Helbing, 2017, Endothelial BMP4 regulates leukocyte diapedesis and promotes inflammation, Inflammation., 40, 1862, 10.1007/s10753-017-0627-0 · DOI
- Heinke, 2008, BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis, Circ Res., 103, 804, 10.1161/CIRCRESAHA.108.178434 · DOI · Paper page
- Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat Genet., 41, 478, 10.1038/ng.320 · DOI · Paper page
- Kim, 2001, Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart, Dev Biol., 235, 449, 10.1006/dbio.2001.0284 · DOI · Paper page
- Banach, 2016, Bone morphogenetic protein 6-a possible new player in pathophysiology of heart failure, Clin Exp Pharmacol Physiol., 43, 1247, 10.1111/1440-1681.12665 · DOI
- Helder, 1995, Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development, J Histochem Cytochem., 43, 1035, 10.1177/43.10.7560881 · doi:10.1177/43.10.7560881
- Dudley, 1997, Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos, Dev Dyn., 208, 349, 10.1002/(SICI)1097-0177(199703)208:3<349::AID-AJA6>3.0.CO;2-I · DOI · Paper page
- Merino, 2016, BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery, Cardiovasc Res., 110, 331, 10.1093/cvr/cvw076 · DOI
- Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat Med., 13, 952, 10.1038/nm1613 · DOI · Paper page
- Urbina, 2014, BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy, Am J Physiol Heart Circ Physiol., 307, H762, 10.1152/ajpheart.00367.2014 · DOI
- Jin, 2018, Exogenous BMP-7 facilitates the recovery of cardiac function after acute myocardial infarction through counteracting TGF-β 1 signaling pathway, Tohoku J Exp Med., 244, 1, 10.1620/tjem.244.1 · DOI
- Huang, 2012, Myocardin regulates BMP10 expression and is required for heart development, J Clin Invest., 122, 3678, 10.1172/JCI63635 · DOI
- Chen, 2004, BMP10 is essential for maintaining cardiac growth during murine cardiogenesis, Development., 131, 2219, 10.1242/dev.01094 · DOI · Paper page
- Susan-Resiga, 2011, Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10, J Biol Chem., 286, 22785, 10.1074/jbc.M111.233577 · DOI
- Mitrofan, 2017, Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-alpha-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2, J Biol Chem., 292, 13714, 10.1074/jbc.M117.778506 · DOI
- Nakano, 2007, Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy, Am J Physiol Heart Circ Physiol., 293, H3396, 10.1152/ajpheart.00311.2007 · DOI
- Sun, 2014, Bone morphogenetic protein-10 induces cardiomyocyte proliferation and improves cardiac function after myocardial infarction, J Cell Biochem., 115, 1868, 10.1002/jcb.24856 · DOI
- Biesemann, 2014, Myostatin regulates energy homeostasis in the heart and prevents heart failure, Circ Res., 115, 296, 10.1161/CIRCRESAHA.115.304185 · DOI
- Sharma, 1999, Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct, J Cell Physiol., 180, 1, 10.1002/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.3.CO;2-M · DOI
- Castillero, 2015, Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy, Biochem Biophys Res Commun., 457, 106, 10.1016/j.bbrc.2014.12.057 · DOI
- Lim, 2018, Absence of myostatin improves cardiac function following myocardial infarction, Heart Lung Circ., 27, 693, 10.1016/j.hlc.2017.05.138 · DOI
- Li, 2008, Myostatin directly regulates skeletal muscle fibrosis, J Biol Chem., 283, 19371, 10.1074/jbc.M802585200 · DOI · Paper page
- Biesemann, 2015, Myostatin induces interstitial fibrosis in the heart via TAK1 and p38, Cell Tissue Res., 361, 779, 10.1007/s00441-015-2139-2 · DOI
- Artaza, 2008, Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts, J Endocrinol., 196, 235, 10.1677/JOE-07-0408 · DOI
- Walker, 2016, Biochemistry and biology of GDF11 and myostatin: similarities, differences, and questions for future investigation, Circ Res., 118, 1125, 10.1161/CIRCRESAHA.116.308391 · DOI · Paper page
- Smith, 2015, GDF11 does not rescue aging-related pathological hypertrophy, Circ Res., 117, 926, 10.1161/CIRCRESAHA.115.307527 · DOI · Paper page
- Harper, 2018, GDF11 decreases pressure overload-induced hypertrophy, but can cause severe cachexia and premature death, Circ Res., 123, 1220, 10.1161/CIRCRESAHA.118.312955 · DOI
- Du, 2017, Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury, Basic Res Cardiol., 112, 7, 10.1007/s00395-016-0593-y · DOI
- Su, 2019, Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury, Basic Res Cardiol., 114, 20, 10.1007/s00395-019-0728-z · DOI
- Luan, 2019, GDF15 is an inflammation-induced central mediator of tissue tolerance, Cell., 178, 1231, 10.1016/j.cell.2019.07.033 · DOI · Paper page
- Wang, 2017, GDF15 is a heart-derived hormone that regulates body growth, EMBO Mol Med., 9, 1150, 10.15252/emmm.201707604 · DOI
- Kempf, 2007, Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction, Eur Heart J., 28, 2858, 10.1093/eurheartj/ehm465 · DOI · Paper page
- Wollert, 2007, Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome, Circulation., 116, 1540, 10.1161/CIRCULATIONAHA.107.697714 · DOI · Paper page
- Wollert, 2007, Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome, Circulation., 115, 962, 10.1161/CIRCULATIONAHA.106.650846 · DOI · Paper page
- Bloise, 2019, Activin A in mammalian physiology, Physiol Rev., 99, 739, 10.1152/physrev.00002.2018 · DOI · Paper page
- Walton, 2012, New insights into the mechanisms of activin action and inhibition, Mol Cell Endocrinol., 359, 2, 10.1016/j.mce.2011.06.030 · DOI
- Yndestad, 2004, Elevated levels of activin A in heart failure: potential role in myocardial remodeling, Circulation., 109, 1379, 10.1161/01.CIR.0000120704.97934.41 · DOI · Paper page
- Chen, 2014, Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury, Cytokine., 69, 255, 10.1016/j.cyto.2014.06.017 · DOI
- Oshima, 2009, Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury, Circulation., 120, 1606, 10.1161/CIRCULATIONAHA.109.872200 · DOI
- Hu, 2016, Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 and p38-MAPK pathways, Eur J Pharmacol., 789, 319, 10.1016/j.ejphar.2016.07.053 · DOI
- Hu, 2018, Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats, Mol Med Rep., 17, 5074, 10.3892/mmr.2018.8496 · doi:10.3892/mmr.2018.8496
- Shimano, 2011, Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy, J Biol Chem., 286, 9840, 10.1074/jbc.M110.197079 · DOI
- Panse, 2012, Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes, J Cardiovasc Transl Res., 5, 814, 10.1007/s12265-012-9400-9 · DOI
- Massague, 2000, How cells read TGF-β signals, Nat Rev Mol Cell Biol., 1, 169, 10.1038/35043051 · DOI · Paper page
- Rahimi, 2007, TGF-β signaling: a tale of two responses, J Cell Biochem., 102, 593, 10.1002/jcb.21501 · DOI · Paper page
- Goumans, 2002, Balancing the activation state of the endothelium via two distinct TGF-β type I receptors, Embo J., 21, 1743, 10.1093/emboj/21.7.1743 · DOI · Paper page
- Funaba, 2002, Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase, J Biol Chem., 277, 41361, 10.1074/jbc.M204597200 · DOI · Paper page
- Kretzschmar, 1999, A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras, Genes Dev., 13, 804, 10.1101/gad.13.7.804 · DOI · Paper page
- Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-β family signalling, Nature., 425, 577, 10.1038/nature02006 · DOI · Paper page
- Kong, 2018, Opposing actions of fibroblast and cardiomyocyte Smad3 signaling in the infarcted myocardium, Circulation., 137, 707, 10.1161/CIRCULATIONAHA.117.029622 · DOI · Paper page
- Chen, 2019, Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation, Circ Res., 125, 55, 10.1161/CIRCRESAHA.119.315069 · DOI · Paper page
- Huang, 2019, Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart, J Mol Cell Cardiol., 132, 84, 10.1016/j.yjmcc.2019.05.006 · DOI
- Tan, 2010, Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction, Am J Physiol Heart Circ Physiol., 298, H1415, 10.1152/ajpheart.01048.2009 · DOI
- Masaki, 2005, Smad1 protects cardiomyocytes from ischemia-reperfusion injury, Circulation., 111, 2752, 10.1161/CIRCULATIONAHA.104.490946 · DOI
- Kumagai, 2016, Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction, Cardiovasc Res., 109, 272, 10.1093/cvr/cvv273 · DOI
- Engel, 1999, Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription, J Biol Chem., 274, 37413, 10.1074/jbc.274.52.37413 · DOI · Paper page
- Yu, 2002, TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses, Embo J., 21, 3749, 10.1093/emboj/cdf366 · DOI · Paper page
- Matsumoto-Ida, 2006, Activation of TGF-β 1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats, Am J Physiol Heart Circ Physiol., 290, H709, 10.1152/ajpheart.00186.2005 · DOI
- Molkentin, 2017, Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis, Circulation., 136, 549, 10.1161/CIRCULATIONAHA.116.026238 · DOI · Paper page
- Bageghni, 2018, Cardiac fibroblast-specific p38alpha MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism, FASEB J., 32, 4941, 10.1096/fj.201701455RR · DOI
- Leask, 2010, Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation, Circ Res., 106, 1675, 10.1161/CIRCRESAHA.110.217737 · DOI · Paper page
- Frangogiannis, 2014, The inflammatory response in myocardial injury, repair, and remodelling, Nat Rev Cardiol., 11, 255, 10.1038/nrcardio.2014.28 · DOI · Paper page
- Frangogiannis, 2014, Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: benefits and perils, J Mol Cell Cardiol., 76, 169, 10.1016/j.yjmcc.2014.09.001 · DOI
- Tan, 2013, SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS, J Am Heart Assoc., 2, e000269, 10.1161/JAHA.113.000269 · DOI
- Biernacka, 2015, Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice, Circ Heart Fail., 8, 788, 10.1161/CIRCHEARTFAILURE.114.001963 · DOI
- Regalado, 2011, Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms, Circ Res., 109, 680, 10.1161/CIRCRESAHA.111.248161 · DOI · Paper page
Cited by
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Gómez-Virgilio, L., Silva-Lucero, M.-D.-C., Flores-Morelos, D.-S., Gallardo-Nieto, J., Lopez-Toledo, G., Abarca-Fernandez, A.-M., Zacapala-Gómez, A.-E., Luna-Muñoz, J., Montiel-Sosa, F., Soto-Rojas, L. O., et al. (2022) · Cells · doi:10.3390/cells11152262 · Cited by 431
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
Zhang, H., & Dhalla, N. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021082 · Cited by 385
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 361
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Self-citation
Metadata
- Authors
- Hanna, A., & Frangogiannis, N. G.
- Venue
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Published
- 2019-09-18
- Volume
- 6
- Pages
- 140-140
- ISSN
- 2297-055X (ISSN-L)
- OpenAlex
- W2971555794
- Cited by
- 251
- References
- 17
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Heart, Lung, and Blood Institute (R01 HL76246)
- U.S. Department of Defense (PR151134)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of the TGF-β Superfamily in Myocardial Infarction. https://app.cochat.ai/papers/10.3389/fcvm.2019.00140
- The paper
- Hanna, A., & Frangogiannis, N. G. (2019). The Role of the TGF-β Superfamily in Myocardial Infarction. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2019.00140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.